BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Melanoma Institute Australia
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20280401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20280930T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260619T004557
CREATED:20260602T045536Z
LAST-MODIFIED:20260602T045536Z
UID:10000303-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF EMCR Initiative - Early to Mid-Career Researchers Grant
DESCRIPTION:The Medical Research Future Fund (MRFF) –2026 Early to Mid-Career Researchers Grant Opportunity will support research to build and grow research capacity and capability in Australia by supporting Early to Mid-Career Researchers (EMCRs) to continue their health and medical research careers. \nThe objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \n\nStream 1 (Incubator): conduct early stage\, small scale research\, led by early career researchers\, that seeks to assess the potential and feasibility of novel strategies to address a critical or intractable health issue in one or more Priority Populations.\nStream 2 (Accelerator): establish a large-scale interdisciplinary research program\, led by mid-career researchers\, that drives implementation of substantial improvements to health care and/or health system effectiveness for one or more Priority Populations.\nStream 3 (Targeted Call for Research): utilise co-funding to accelerate the translation of research led by early or mid-career researchers into policy and practice. (Note: a priority population focus is not required).\n\nThe intended outcome of the research is to improve the health and wellbeing of Australians by: \n\nStream 1 (Incubator): supporting early career researchers to develop innovative solutions for addressing significant health challenges in Priority Populations.\nStream 2 (Accelerator): supporting mid-career researchers to transform health practice and/or policy for Priority Populations.\nStream 3 (Targeted Call for Research): supporting early to mid-career researchers to translate new health solutions into practice.\n\n\nKey Dates:\nMinimum data due: 22 July 2026\nApplications close: 19 August 2026\nGrant activity timeframe: February 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-emcr-initiative/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/MRFF-EMCR-Initiative-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260821T170000
DTEND;TZID=Australia/Sydney:20260821T170000
DTSTAMP:20260619T004557
CREATED:20260618T060727Z
LAST-MODIFIED:20260618T060727Z
UID:10000311-1787331600-1787331600@melanoma.org.au
SUMMARY:TOUR DE CURE Annual Grants
DESCRIPTION:We are proud to open a new Annual Grants Round in 2026\, made possible by the continued support of our community\, partners\, and fundraisers. \nThis year’s Grant Round is open to applications in the following categories: \n• Early Career Research Grant\n• PhD Scholarship\n• Prof Richard Scolyer Award for Brain Cancer Research for Early\, Mid and Senior Career Researchers \nThe Tour de Cure Grants Committee follows an ethical\, independent\, and transparent selection process when reviewing applications. \nWe are committed to funding innovation and excellence\, using our resources to support the best Australian-based projects and researchers. As a cancer-agnostic organisation\, we consider applications across all cancer types. \nDemonstrating a rigorous selection process\, choosing the strongest projects\, and maintaining sound project governance – all grant applications are assessed on merit. \nAn EOI (Expression of Interest) is required for all research grant categories listed. EOIs are reviewed in Round One by the Tour de Cure Grants Committee. Successful applicants are then invited to submit a full grant application in Round Two\, which is assessed in detail by the Grants Committee who then makes recommendations to the TDC Board for final decisions in December. \nInstitutions supporting individual researchers may submit no more than two applications per grant category. This limit applies even where an intermediary body\, such as a foundation\, applies on behalf of the researcher. There is no limit on the number of PhD Scholarship applications but please be mindful of your submission numbers. \n\nKey Dates:\nExpressions of Interest open: 1 August 2026\nExpressions of Interest close: 21 August 2026\nExpressions of Interest outcomes notified: 8 October 2026\nFull grant applications open (by invitation): 9 October 2026\nFull grant applications close: 24 October 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/tour_de_cure_grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/Tour-de-Cure_Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260916T170000
DTEND;TZID=Australia/Sydney:20260916T170000
DTSTAMP:20260619T004557
CREATED:20260602T045957Z
LAST-MODIFIED:20260602T045957Z
UID:10000300-1789578000-1789578000@melanoma.org.au
SUMMARY:MRFF International Clinical Trial Collaborations
DESCRIPTION:The objective of the Medical Research Future Fund (MRFF) – 2026 International Clinical Trial Collaborations Grant Opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \n\nPromote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.\nProvide high-quality evidence of the effectiveness of novel health treatments\, drugs or devices in ‘usual care’ settings\, which will support a decision on whether to deliver the intervention in an Australian setting.\n\nThe anticipated outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality\, evidence-based and effective health care. \nPlease note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only. \n\nKey Dates:\nMinimum data due: 19 August 2026\nApplications close: 16 September 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-int-clinical-trial-collaborations/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-International-Clinical-Trial-Collaborations-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261014T170000
DTEND;TZID=America/Halifax:20261014T170000
DTSTAMP:20260619T004557
CREATED:20260602T051105Z
LAST-MODIFIED:20260602T051105Z
UID:10000302-1791997200-1791997200@melanoma.org.au
SUMMARY:CDMRP Melanoma Research Program
DESCRIPTION:The Melanoma Research Program (MRP) released program announcements for the following funding opportunities: \n\n\n\n·        Focused Program Award – Rare Melanomas  \nThis award supports a multidisciplinary research program of at least two\, but not more than three\, distinct but complementary research projects addressing an overarching question relevant to rare melanomas. \n·        Idea Award \nThe Idea Award supports innovative\, exploratory\, high-risk/potentially high-reward research. Novelty and innovation are expected to be key aspects of the proposed project. By the end of the Idea Award funding period\, the anticipated outcomes of successful efforts should establish proof of principle and obtain preliminary data to secure follow-on funding. \n·        Melanoma Academy Scholar Award \nSupports the addition of independent\, early career investigators (Scholars) who are no more than seven years from their initial faculty appointment to the Melanoma Research Program (MRP) Melanoma Academy. The Melanoma Academy is a unique\, interactive virtual academy focused on bringing together established investigators and Scholars to develop a network of successful\, highly productive melanoma researchers in a collaborative research and career development environment. \n·        Survivorship Research Award \nThe award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors\, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life\, overall health and/or function are not responsive to this funding opportunity. \n·        Team Science Award \nSupports a broad range of hypothesis-driven\, multidisciplinary studies that have a short-term goal of advancing the state of the science in melanoma research and/or patient care. Team science is a synergistic effort that harnesses techniques\, approaches and perspectives from multiple disciplines and/or therapeutic areas to address complex\, multi-dimensional problems that will impact patient outcomes. \nKey Dates: \nSubmission Deadline (Pre-application-Pre-Proposal): 13 July 2026\nFocused Program Award – Rare Melanomas\nIdea Award\nTeam Science Award \nSubmission Deadline (Pre-application-Pre-Proposal): 22 September 2026\nMelanoma Academy Scholar Award\nSurvivorship Research Award \nApplication Submission Deadline: 14 October 2026 \n\n\n\n\n\n\n\n\n\nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/cdmrp-melanoma-program/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/CDMRP-Research-Program-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260619T004557
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20270331T170000
DTEND;TZID=Australia/Sydney:20270331T170000
DTSTAMP:20260619T004557
CREATED:20260618T051009Z
LAST-MODIFIED:20260618T051009Z
UID:10000310-1806512400-1806512400@melanoma.org.au
SUMMARY:MRFF 2022 Frontier Health and Medical Research Grant
DESCRIPTION:This grant program will support researchers to pursue big ideas to develop new products and interventions and implement these into clinical practice\, benefiting patients\, clinicians\, and the health system. \nThis grant opportunity offers funding to support medical research and medical innovation programs of research (up to $25 million per program) that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition\, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re‑purpose existing health technologies in a novel way. \nThe initial application process to secure funding through this grant opportunity will be conducted in two stages: \n\nexpression of interest (EOI) – outlining a proposed program of research comprising of a series of linked projects with a 10-year time horizon\nfull application\, (invitation only – following EOI) for a project of up to 5 years under the program of research.\n\nApplicants may propose to commence research at any stage in the research pipeline from proof-of-concept\, with the intention of achieving full implementation of the proposed technology in 10 years. \nFunding for subsequent projects under the program of research that continue to progress the technology towards full implementation can be sought by submitting additional full applications to this grant opportunity (i.e. applicants do not need to recommence with an EOI). These applications may be submitted by invitation only. \n\nKey Dates:\nExpressions of Interest close: 31 March 2027\nLast grants awarded by: 30 June 2028 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-2022-frontier-grant/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/MRFF-2022-Frontier-Health-and-Medical-Research-Grant-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR